BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17954240)

  • 1. Real-time cell assays of phospholipase A(2)s using fluorogenic phospholipids.
    Manna D; Cho W
    Methods Enzymol; 2007; 434():15-27. PubMed ID: 17954240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles for phospholipase A2 enzymes in cancer.
    Scott KF; Sajinovic M; Hein J; Nixdorf S; Galettis P; Liauw W; de Souza P; Dong Q; Graham GG; Russell PJ
    Biochimie; 2010 Jun; 92(6):601-10. PubMed ID: 20362028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.
    Magrioti V; Kokotos G
    Expert Opin Ther Pat; 2010 Jan; 20(1):1-18. PubMed ID: 20021282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase A(1) assays using a radiolabeled substrate and mass spectrometry.
    Morikawa R; Tsujimoto M; Arai H; Aoki J
    Methods Enzymol; 2007; 434():1-13. PubMed ID: 17954239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of intracellular phospholipase A1 and A2 in Giardia lamblia.
    Vargas-Villarreal J; Escobedo-Guajardo BL; Mata-Cárdenas BD; Palacios-Corona R; Cortes-Gutiérrez E; Morales-Vallarta M; Sampayo-Reyes A; Said-Fernández S
    J Parasitol; 2007 Oct; 93(5):979-84. PubMed ID: 18163329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase A2 activity-independent membrane-damaging effect of notexin.
    Kao PH; Lin SR; Chang LS
    Toxicon; 2007 Dec; 50(7):952-9. PubMed ID: 17889218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of phospholipase A(2) activity in serum of the American alligator (Alligator mississippiensis).
    Merchant M; Heard R; Monroe C
    J Exp Zool A Ecol Genet Physiol; 2009 Nov; 311(9):662-6. PubMed ID: 19642205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfacial mechanism of phospholipase A2: pH-dependent inhibition and Me-beta-cyclodextrin activation.
    Wacklin HP
    Biochemistry; 2009 Jun; 48(25):5874-81. PubMed ID: 19419199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted phospholipase A2 revisited.
    Murakami M; Taketomi Y; Sato H; Yamamoto K
    J Biochem; 2011 Sep; 150(3):233-55. PubMed ID: 21746768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phospholipase A(2) as a therapeutic target.
    Yedgar S; Lichtenberg D; Schnitzer E
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):182-7. PubMed ID: 11080687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cytosolic phospholipase A(2), calcium independent phospholipase A(2) and plasmalogen selective phospholipase A(2) in neurodegenerative and neuropsychiatric conditions.
    Ong WY; Farooqui T; Farooqui AA
    Curr Med Chem; 2010; 17(25):2746-63. PubMed ID: 20586719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory interaction of the Galpha protein with phospholipase A2 in the plasma membrane of Eschscholzia californica.
    Heinze M; Steighardt J; Gesell A; Schwartze W; Roos W
    Plant J; 2007 Dec; 52(6):1041-51. PubMed ID: 17916111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
    da Silva SL; Calgarotto AK; Maso V; Damico DC; Baldasso P; Veber CL; Villar JA; Oliveira AR; Comar M; Oliveira KM; Marangoni S
    Eur J Med Chem; 2009 Jan; 44(1):312-21. PubMed ID: 18423943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems wide analyses of lipids in the brainstem during inflammatory orofacial pain - evidence of increased phospholipase A(2) activity.
    Ma MT; Yeo JF; Shui G; Wenk MR; Ong WY
    Eur J Pain; 2012 Jan; 16(1):38-48. PubMed ID: 21783394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence single-molecule study of cobra phospholipase A2 action on a supported gel-phase lipid bilayer.
    Chiu CR; Huang WN; Wu WG; Yang TS
    Chemphyschem; 2009 Feb; 10(3):549-58. PubMed ID: 19142925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorogenic phospholipids as head group-selective reporters of phospholipase A activity.
    Rose TM; Prestwich GD
    ACS Chem Biol; 2006 Mar; 1(2):83-91. PubMed ID: 17163648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights of secretory phospholipase a(2) action in cardiology.
    Fujioka D; Kugiyama K
    Trends Cardiovasc Med; 2009 Apr; 19(3):100-3. PubMed ID: 19679267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2 biochemistry.
    Burke JE; Dennis EA
    Cardiovasc Drugs Ther; 2009 Feb; 23(1):49-59. PubMed ID: 18931897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic phospholipase A2 as a mediator of disease pathogenesis.
    Linkous A; Yazlovitskaya E
    Cell Microbiol; 2010 Oct; 12(10):1369-77. PubMed ID: 20642808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyunsaturated fatty acid-phospholipid remodeling and inflammation.
    Robichaud PP; Surette ME
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):112-8. PubMed ID: 25692925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.